Epidemiological and economic burden of pneumococcal diseases in Canadian children

Canadian Journal of Infectious Diseases

Volumn 14, Issue 4, 2003, Pages 215-220

  Petit, Geneviève ^a   De Wals, Philippe ^b,c   Law, Barbara ^d   Tam, Theresa ^e   Erickson, Lonny James ^f   Guay, Maryse ^a,c,f   Framarin, Alicia ^g  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f Regional Health Board of Monteregie   (Canada)

^g Quebec Health Services and Technology Assessment Agency   (Canada)

Author keywords

Canada; Economics; Epidemiology; Pneumococcal infections

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CANADA; CHILD; COST OF ILLNESS; DEATH; ECONOMIC ASPECT; HEALTH CARE SYSTEM; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MYRINGOTOMY; OTITIS MEDIA; PNEUMONIA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VENTILATOR;

EID: 0142054944     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/781794     Document Type: Article

References (33)

1. Peter G, Klein JO. Streptococcus pneumoniae. In: Long SS, Pickerin LK, Prober CG, eds. Principles and practice of pediatric infectious diseases. New York: Churchill Livingstone, 1997:828-35.
2. National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine. CCDR. 〈 http://www.hc-sc.gc.ca/pphb.dgspsp/publicat/ccdr-rmtc/02vol28/28sup/acs2. html〉 (Version current at June 30, 2003).
3. MacDonald N, Embree J. Access to vaccines: A call to action. Can J Infect Dis 2003;14:9-13.
4. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
5. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Impact on pneumonia, otitis media and an update on invasive disease-Results extended follow-up of the efficacy trial cohort. 2nd International Symposium on Pneumococci and Pneumococcal Diseases. Sun City, South Africa, March 19 to 23, 2000. (Abst)
6. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
7. Statistics Canada. Consumer Price Index, provinces. 〈 http://www.statcan.ca/english/Pgdb/econ09a.htm〉 (Version current at June 30, 2003).
8. Cucherat M. Méta-analyse des essais thérapeutiques. Masson, Paris, 1997.
9. Turner RB, Lande AE, Chase P, Hilton N, Weinberg D. Pneumonia in pediatric outpatients: Cause and clinical manifestations. J Pediatr 1987;111:194-200.
10. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: Serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998;17:986-91.
11. Ramsay BW, Marcuse EK, Foy HM, et al. Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections. Pediatrics 1986;78:1-9.
12. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J 1989;8:856-62.
13. Nohynek H, Eskola J, Laine E, et al. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child 1991;145:618-22.
14. Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997;16:388-91.
15. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999;18:98-104.
16. Juvén T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000;19:293-8.
17. Lieu TA, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000;283:1460-8.
18. Scheifele D, Halperin S, Pelletier L, Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: Implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis. 2000;31:58-64.
19. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993;137:977-88.
20. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitidis: A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
21. Pomeroy SL, Holmes SJ, Dodge PR, et al. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 1990;323:1651-7.
22. Statistics Canada. Life tables, Canada and the Provinces 1990-1992. Catalogue 84-537. Ottawa, 1996.
23. Régie d'Assurance Maladie du Québec, 2000. 〈http://www.ramq.gouv.qc.ca〉 (Version current at June 30, 2003).
24. Coyte PC, Asche CV, Ho E, Brassard T, Friedberg J. Comparative cost analysis of myringotomy with insertion of ventilation tubes in Ontario and British Columbia. J Otolaryngol 1998;27:69-75.
25. Beutels P. Economic evaluation of vaccination programmes in humans: A methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination. Antwerp: Universiteit Antwerpen. Faculteit Geneeskunde, 2002.
26. Advisory Committee on Immunization Practices (ACIP). Preventing pneumococcal disease among infants and young children. MMWR 2000;49(RR09):1-38.
27. Bjornson GL, Scheifele DW, Halperin SA. Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998. Canadian Paediatric Society/Health Canada Immunization Monitoring Program, Active. Pediatr Infect Dis J 2002;21:947-50.
28. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, MCGowan KL. Occult bacteremia from a pediatric emergency department: Current prevalence, time to detection, and outcome. Pediatrics 2000;106:505-11.
29. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: A prospective, cohort study. J Infect Dis 1989;160:83-94.
30. Desai SN, Kellner JD, Drummond D. Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada. Pediatr Infect Dis J 2002;21:348-50.
31. National Advisory Committee on Immunization (NACI). Statement on recommended use of varicella virus vaccine. CCDR. 〈 http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/99vol25/25sup/acsl. html〉(Version current at June 30, 2003).
32. National Advisory Committee on Immunization (NACI). Statement on recommended use of meningococcal vaccines. CCDR. 〈 http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/01vol27/27sup/acs6. html33〉 (Version current at June 30, 2003).
33. De Wals P, Allard MA, Guindon K, et al. Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region. CCDR. 〈 http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/02vol28/dr2808ea. html〉 (Version current at June 30, 2003).